Published in Gan To Kagaku Ryoho on October 01, 2005
Phase III study, V-15-32, of gefitinib versus docetaxel in previously treated Japanese patients with non-small-cell lung cancer. J Clin Oncol (2008) 3.27
Clinicopathologic and biological analysis of PIK3CA mutation in ovarian clear cell carcinoma. Hum Pathol (2012) 2.27
Diffusion-weighted imaging of malignant breast tumors: the usefulness of apparent diffusion coefficient (ADC) value and ADC map for the detection of malignant breast tumors and evaluation of cancer extension. J Comput Assist Tomogr (2005) 2.05
ADC mapping of benign and malignant breast tumors. Magn Reson Med Sci (2005) 2.02
Brain natriuretic peptide on admission as a biological marker of long-term mortality in ischemic stroke survivors. Eur Neurol (2013) 2.00
Phase II trial of amrubicin for treatment of refractory or relapsed small-cell lung cancer: Thoracic Oncology Research Group Study 0301. J Clin Oncol (2006) 1.88
Evaluation of acoustic radiation force impulse elastography for fibrosis staging of chronic liver disease: a pilot study. Liver Int (2009) 1.82
PDGFRA gene rearrangements are frequent genetic events in PDGFRA-amplified glioblastomas. Genes Dev (2010) 1.82
The presence of a right-to-left shunt is associated with dramatic improvement after thrombolytic therapy in patients with acute ischemic stroke. Stroke (2008) 1.64
Routine use of intravenous low-dose recombinant tissue plasminogen activator in Japanese patients: general outcomes and prognostic factors from the SAMURAI register. Stroke (2009) 1.63
Relationships between angiographic findings and National Institutes of Health stroke scale score in cases of hyperacute carotid ischemic stroke. AJNR Am J Neuroradiol (2004) 1.61
Mechanism of c-Myb-C/EBP beta cooperation from separated sites on a promoter. Cell (2002) 1.59
A phase II study of topotecan in patients with relapsed small-cell lung cancer. Clin Lung Cancer (2003) 1.59
Mature adipocytes, but not preadipocytes, promote the growth of breast carcinoma cells in collagen gel matrix culture through cancer-stromal cell interactions. J Pathol (2003) 1.56
EGFR genetic heterogeneity of nonsmall cell lung cancers contributing to acquired gefitinib resistance. Int J Cancer (2008) 1.55
Differential expression of Janus kinase 3 (JAK3), matrix metalloproteinase 13 (MMP13), heat shock protein 60 (HSP60), and mouse double minute 2 (MDM2) in human colorectal cancer progression using human cancer cDNA microarrays. Pathol Res Pract (2005) 1.51
Phase I study of YM155, a novel survivin suppressant, in patients with advanced solid tumors. Clin Cancer Res (2009) 1.51
Early ischaemic diffusion lesion reduction in patients treated with intravenous tissue plasminogen activator: infrequent, but significantly associated with recanalization. Int J Stroke (2012) 1.49
Source of microembolic signals in patients with high-grade carotid stenosis. Stroke (2002) 1.48
Epidermal growth factor receptor mutation status and clinicopathological features of combined small cell carcinoma with adenocarcinoma of the lung. Cancer Sci (2007) 1.47
Intracranial Hemorrhage Caused by Non-Vitamin K Antagonist Oral Anticoagulants (NOACs)- Multicenter Retrospective Cohort Study in Japan. Circ J (2015) 1.47
Tumor progression through epigenetic gene silencing of O(6)-methylguanine-DNA methyltransferase in human biliary tract cancers. Ann Surg Oncol (2005) 1.47
Silencing effect of CpG island hypermethylation and histone modifications on O6-methylguanine-DNA methyltransferase (MGMT) gene expression in human cancer. Oncogene (2003) 1.47
Linear fractures occult on skull radiographs: a pitfall at radiological screening for mild head injury. J Trauma (2011) 1.44
Contrast transcranial Doppler can diagnose large patent foramen ovale. Cerebrovasc Dis (2009) 1.42
Guidelines for the intravenous application of recombinant tissue-type plasminogen activator (alteplase), the second edition, October 2012: a guideline from the Japan Stroke Society. J Stroke Cerebrovasc Dis (2013) 1.40
Relative systolic blood pressure reduction and clinical outcomes in hyperacute intracerebral hemorrhage: the SAMURAI-ICH observational study. J Hypertens (2015) 1.40
Loss of ARID1A expression is related to shorter progression-free survival and chemoresistance in ovarian clear cell carcinoma. Mod Pathol (2011) 1.38
Hypoxia-inducible factor 1 alpha (HIF-1 alpha) gene expression in human ovarian carcinoma. Cancer Lett (2002) 1.29
Tumor-stromal cell interaction under hypoxia increases the invasiveness of pancreatic cancer cells through the hepatocyte growth factor/c-Met pathway. Int J Cancer (2006) 1.28
FLAIR can estimate the onset time in acute ischemic stroke patients. J Neurol Sci (2010) 1.27
Identification of residual breast carcinoma following neoadjuvant chemotherapy: diffusion-weighted imaging--comparison with contrast-enhanced MR imaging and pathologic findings. Radiology (2010) 1.26
Enhanced carotid plaque on contrast-enhanced ultrasound is associated with plaque instability and rupture. Int J Stroke (2012) 1.15
Relation of atrial fibrillation to glomerular filtration rate. Am J Cardiol (2008) 1.15
Prevalence of atrial fibrillation in community-dwelling Japanese aged 40 years or older in Japan: analysis of 41,436 non-employee residents in Kurashiki-city. Circ J (2008) 1.13
Value of high-dose radiation therapy for isolated osseous metastasis in breast cancer in terms of oligo-recurrence. Anticancer Res (2009) 1.13
Comparison of multivisceral resection and standard operation for locally advanced colorectal cancer: analysis of prognostic factors for short-term and long-term outcome. Dis Colon Rectum (2004) 1.12
Intravenous thrombolysis based on diffusion-weighted imaging and fluid-attenuated inversion recovery mismatch in acute stroke patients with unknown onset time. Cerebrovasc Dis (2011) 1.12
Plasma brain natriuretic peptide can be a biological marker to distinguish cardioembolic stroke from other stroke types in acute ischemic stroke. Intern Med (2009) 1.11
Reduced estimated glomerular filtration rate is associated with stroke outcome after intravenous rt-PA: the Stroke Acute Management with Urgent Risk-Factor Assessment and Improvement (SAMURAI) rt-PA registry. Cerebrovasc Dis (2010) 1.11
Expression of RACK1 is a novel biomarker in pulmonary adenocarcinomas. Lung Cancer (2009) 1.09
Copper-transporting P-type adenosine triphosphatase (ATP7B) as a cisplatin based chemoresistance marker in ovarian carcinoma: comparative analysis with expression of MDR1, MRP1, MRP2, LRP and BCRP. Int J Cancer (2002) 1.09
Plasma brain natriuretic peptide as an independent predictor of in-hospital mortality after acute ischemic stroke. Intern Med (2009) 1.09
A case of autoimmune thyroid disease presenting posterior reversible encephalopathy syndrome. J Neurol Sci (2008) 1.08
The Critical Impact of HIF-1a on Gastric Cancer Biology. Cancers (Basel) (2013) 1.08
The hypoxic environment in tumor-stromal cells accelerates pancreatic cancer progression via the activation of paracrine hepatocyte growth factor/c-Met signaling. Ann Surg Oncol (2007) 1.07
Induction of hepatocyte growth factor activator gene expression under hypoxia activates the hepatocyte growth factor/c-Met system via hypoxia inducible factor-1 in pancreatic cancer. Cancer Sci (2008) 1.07
Reduced retinal ganglion cell complex thickness in patients with posterior cerebral artery infarction detected using spectral-domain optical coherence tomography. Jpn J Ophthalmol (2012) 1.07
Large numbers of stroke physicians should be used to treat large numbers of stroke patients with IV rt-PA. J Neurol Sci (2010) 1.07
Silencing of imprinted CDKN1C gene expression is associated with loss of CpG and histone H3 lysine 9 methylation at DMR-LIT1 in esophageal cancer. Oncogene (2004) 1.06
Multiple inflammatory pseudotumor of the liver, mimicking cholangiocarcinoma with tumor embolus in the hepatic vein: report of a case. Surg Today (2007) 1.05
Randomized phase III trial of trastuzumab monotherapy followed by trastuzumab plus docetaxel versus trastuzumab plus docetaxel as first-line therapy in patients with HER2-positive metastatic breast cancer: the JO17360 Trial Group. Breast Cancer Res Treat (2009) 1.05
Intrahepatic multicystic biliary hamartoma: report of a case. Hepatol Res (2008) 1.04
A case of stroke due to tumor emboli associated with metastatic cardiac liposarcoma. Intern Med (2011) 1.04
Gastrointestinal function and quality of life after pylorus-preserving pancreatoduodenectomy. J Hepatobiliary Pancreat Surg (2006) 1.03
Signet ring cell carcinoma of the lower bile duct with rapid growth: report of a case. Hepatogastroenterology (2008) 1.03
Ribonucleotide reductase subunit M1 is a possible chemoresistance marker to gemcitabine in biliary tract carcinoma. Oncol Rep (2008) 1.02
Expression of the bric-a-brac tramtrack broad complex protein NAC-1 in cervical carcinomas seems to correlate with poorer prognosis. Clin Cancer Res (2008) 1.02
Annual incidence of atrial fibrillation and related factors in adults. Am J Cardiol (2010) 1.02
Clinical significance of CEA and CA19-9 in postoperative follow-up of colorectal cancer. Ann Surg Oncol (2010) 1.02
Pituitary apoplexy manifesting as diffuse subarachnoid hemorrhage. Neurol Med Chir (Tokyo) (2006) 1.01
Utility of the Kurashiki Prehospital Stroke Scale for hyperacute stroke. Cerebrovasc Dis (2010) 1.01
Taxane-induced peripheral neuropathy and health-related quality of life in postoperative breast cancer patients undergoing adjuvant chemotherapy: N-SAS BC 02, a randomized clinical trial. Support Care Cancer (2012) 1.00
Hepatectomy of segment 4a and 5 combined with extra-hepatic bile duct resection for T2 and T3 gallbladder carcinoma. J Surg Oncol (2008) 1.00
The significance of aberrant CHFR methylation for clinical response to microtubule inhibitors in gastric cancer. J Gastroenterol (2006) 1.00
Phase II study of erlotinib in Japanese patients with advanced non-small cell lung cancer. Anticancer Res (2010) 0.99
First impression at stroke onset plays an important role in early hospital arrival. Intern Med (2006) 0.99
Biological role and prognostic significance of NAC1 in ovarian cancer. Gynecol Oncol (2010) 0.99
Tumor-specific cytotoxic T cell generation and dendritic cell function are differentially regulated by interleukin 27 during development of anti-tumor immunity. Int J Cancer (2009) 0.99
Prognostic value of the Cu-transporting ATPase in ovarian carcinoma patients receiving cisplatin-based chemotherapy. Clin Cancer Res (2004) 0.98
A BTB/POZ gene, NAC-1, a tumor recurrence-associated gene, as a potential target for Taxol resistance in ovarian cancer. Clin Cancer Res (2008) 0.98
Efficacy of endovascular surgery for the treatment of acute epidural hematomas. AJNR Am J Neuroradiol (2004) 0.98
Evaluation of the antiangiogenic effect of Taxol in a human epithelial ovarian carcinoma cell line. Cancer Chemother Pharmacol (2003) 0.98
Helicobacter pylori infection is an independent risk factor for Runx3 methylation in gastric cancer. Oncol Rep (2008) 0.97
Diffusion-weighted magnetic resonance images in a patient with neuropsychiatric lupus. J Clin Neurosci (2007) 0.97
Neuroendoscopic appearance of an intraventricular cavernous angioma blocking the foramen of monro - case report. Neurol Med Chir (Tokyo) (2006) 0.97
Age dependence of fusion of primary occipital sutures: a radiographic study. Childs Nerv Syst (2006) 0.97
Low serum albumin level is risk factor for patients with percutaneous endoscopic gastrostomy. Intern Med (2010) 0.96
HIF-1alpha is an unfavorable determinant of relapse in gastric cancer patients who underwent curative surgery followed by adjuvant 5-FU chemotherapy. Int J Cancer (2010) 0.96
Biological and clinical significance of NAC1 expression in cervical carcinomas: a comparative study between squamous cell carcinomas and adenocarcinomas/adenosquamous carcinomas. Hum Pathol (2011) 0.96
M1 susceptibility vessel sign on T2* as a strong predictor for no early recanalization after IV-t-PA in acute ischemic stroke. Stroke (2009) 0.95
Radiofrequency ablation with the real-time virtual sonography system for treating hepatocellular carcinoma difficult to detect by ultrasonography. J Clin Biochem Nutr (2007) 0.95
Iliac lymph node metastasis of an unknown primary tumor: report of a case. Surg Today (2006) 0.94
Relapse of stage I small cell lung cancer ten or more years after the start of treatment. Jpn J Clin Oncol (2006) 0.94
Aberrant methylation of p16 predicts candidates for 5-fluorouracil-based adjuvant therapy in gastric cancer patients. J Gastroenterol (2007) 0.94
Psychological characteristics and subjective symptoms as determinants of psychological distress in patients prior to breast cancer diagnosis. Support Care Cancer (2009) 0.93
Endoscopic hemostasis for bleeding gastric varices treated by combination of variceal ligation and sclerotherapy with N-butyl-2-cyanoacrylate. J Gastroenterol (2007) 0.93
Association between silent brain infarct and arterial stiffness indicated by brachial-ankle pulse wave velocity. Intern Med (2012) 0.93
Prognostic and therapeutic impact of the chromosome 20q13.2 ZNF217 locus amplification in ovarian clear cell carcinoma. Cancer (2011) 0.93
Left ventricular hypertrophy in mice with a cardiac-specific overexpression of interleukin-1. Am J Physiol Heart Circ Physiol (2006) 0.93
Brain natriuretic peptide is a marker associated with thrombus in stroke patients with atrial fibrillation. J Neurol Sci (2010) 0.93
Vertebral artery occlusion in duplex color-coded ultrasonography. Stroke (2004) 0.93
Crystal structure of a ribonuclease P protein Ph1601p from Pyrococcus horikoshii OT3: an archaeal homologue of human nuclear ribonuclease P protein Rpp21. Biochemistry (2005) 0.93
Impact of early blood pressure variability on stroke outcomes after thrombolysis: the SAMURAI rt-PA Registry. Stroke (2013) 0.92
Influence of ovarian cystectomy on the ovulatory function of the residual ovary. Eur J Obstet Gynecol Reprod Biol (2005) 0.92
Structure of an archaeal homolog of the human protein complex Rpp21-Rpp29 that is a key core component for the assembly of active ribonuclease P. J Mol Biol (2008) 0.92
Maternal thyroid function during pregnancy and puerperal period. Endocr J (2005) 0.92